#1HIGH QUALITY, HIGHLY ACCESSIBLE HEALTHCARE FOR ALL DOCGO © 2023 All Rights Reserved DocGo Investor Presentation#2DISCLAIMER This presentation is being delivered solely for informational purposes. No representation or warranty, express or implied, is made by DocGo, its affiliates, or any of their respective directors, officers, shareholders, members, partners or representatives as to the accuracy or completeness of any information in this presentation. Except where otherwise indicated, this presentation speaks as of the date hereof and is necessarily based upon the information as of the date hereof, all of which is subject to change. DocGo has no obligation to update, review or reaffirm this presentation. Nothing contained in this presentation is, or shall be relied upon as, a promise or representation as to the past, present or future. Forward Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the plans, strategies, outcomes, and prospects, both business and financial, of DocGo. These statements are based on the beliefs and assumptions of DocGo's management. Although DocGo believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, DocGo cannot assure you that it will ach or realize these plans, intentions, outcomes, sults or expectations. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond DocGo's control, and which may cause DocGo's actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in DocGo's forward-looking statements. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. Forward-looking statements include, but are not limited to, statements concerning DocGo's possible or assumed future actions, business strategies or models, plans, goals, future events, future revenues, future margins, future guidance, future growth or performance, financing needs, business trends, results of operations, objectives and intentions with respect to future operations, services and products, including DocGo's geographic expansion, its margin normalization initiative, new and existing contracts or partnerships, backlog, M&A activity, workforce growth, leadership transitions, cash position, share repurchase program, expected impacts of macroeconomic factors, including inflationary pressures, general economic slowdown or a recession, rising interest rates, foreign exchange rate volatility, changes in monetary pressure, financial institution instability or the prospect of a shutdown of the U.S. federal government, expected impacts of geopolitical instability, including the conflict in Ukraine, conflict in Israel and surrounding areas and rising tensions between China and Taiwan, its competitive position and opportunities, including its ability to realize the benefits from its operating model, its ability to improve gross margins, cost-containment measures, legislative and regulatory actions, the impact of legal proceedings and compliance risk, the impact on DocGo's business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of DocGo to comply with laws and regulations regarding data privacy and protection and others. In some cases, these statements may be preceded by, followed by or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "might," "will," "should," "could," "can," "would," "design," "potential," "seeks," "plans," "scheduled," "anticipates," "intends" or the negative of these terms or similar expressions. Moreover, DocGo operates in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for DocGo to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this presentation. In addition, statements preceded by "we believe" and similar statements reflect DocGo's beliefs and opinions on the relevant subject. These statements are based on information available to DocGo as of the date of this presentation, and, while DocGo believes that information provides a reasonable basis for these statements, that information may be limited or incomplete. DocGo's statements should not be read to indicate that DocGo has conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this presentation are based on events or circumstances as of the date on which the statements are made. DocGo undertakes no obligation to update any forward-looking statements made in this presentation to reflect events or circumstances after the date of this presentation or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law. DocGo may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. DocGo's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments. Non-GAAP Financial Information This presentation includes references to financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States of America ("GAAP"), such as Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"). DocGo has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this presentation that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this presentation. The non-GAAP financial measures in this presentation may differ from similarly titled measures used by other companies. A reconciliation of certain of these non-GAAP financial measures can be found in the Appendix to this presentation. Market and Industry Data Market data and industry data used throughout this presentation is based on information derived from third party sources, the knowledge of the DocGo management team regarding its industries and businesses and the DocGo management team's good faith estimates. While management of DocGo believes that the third party sources from which market and industry data has been derived are reputable, DocGo has not independently verified such market and industry data, and you are cautioned not to give undue weight to such market and industry data. © 2023 All Rights Reserved - DocGo 2#3DOCGO: LEADING PROVIDER OF TECHNOLOGY- ENABLED MOBILE HEALTHCARE ABOUT DOCGO → ▪ DocGo is a mobile health company that provides services in 30 US states and across the UK The company brings healthcare services to patients where and when they need it - in the home, office or via a fleet of ~1,000 mobile units in the field ▪ Delivery of both mobile health and medical transport services are managed logistically by DocGo's proprietary software platform supporting highly efficient and cost-effective delivery of healthcare Historically strong revenue growth, Q3 2023 revenues of $186.6 million with $4.6 million in Net Income and $16.7 million in Adjusted EBITDA (a) ▪ Raised original 2023 revenue guidance from $500-$510 million to $615-$625 million, Adjusted EBITDA (a) guidance from $45-$50 million to $50-$55 million © 2023 All Rights Reserved - DocGo ING OR EE146449untitled.jpg XX (a) Adjusted EBITDA is a non-GAAP measure, defined as earnings before interest income, interest expense, taxes, depreciation, amortization, stock-based compensation and certain other non-recurring expenses. See the Appendix for a reconciliation of Adjusted EBITDA to the most comparable GAAP measure. We have not reconciled our Adjusted EBITDA outlook to the most comparable GAAP outlook (net income) because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. 3#4DOCGO CLINICAL DELIVERY OF SERVICES DocGo offers a wide variety of services from traditional EMS to mobile urgent care to higher acuity medical services Proven unit economic model utilizes lower-cost health care staff for onsite visits, directed by higher-cost APPs connected virtually via telehealth CLINICAL SERVICES SERVICE DELIVERY BENEFITS TYPICAL SERVICES UTILIZED Chronic Care Management Episodic Care Inoculations Primary/Preventive Care Patient Transport Prescriptions Remote Patient Monitoring Urgent care ...and more © 2023 All Rights Reserved - DocGo ON-SITE CLINICAL STAFF Certified Medical Assistant ■ Emergency Medical Technician Licensed Practical Nurse Paramedic REMOTE CLINICAL STAFF Licensed Medical Physician Physician Assistant Nurse Practitioner Registered Nurse → → P88 Flexible, turnkey solutions for ongoing health management and care gap closure Intelligent use of appropriately-skilled healthcare professionals creates efficiency with quality care Common procedures executed at fraction of average industry cost 4#5MOBILE HEALTH OFFERINGS Tailored programs create value for key segments and help keep patients out of the hospital GOVERNMENT (70% OF REVENUES) ▪ Urgent care for low-income communities Migrant-related care programs Homeless shelter and street-side medicine programs Population and behavioral health initiatives HOSPITALS (20% OF REVENUES) + ▪ Medical transportation Pre/post-surgical programs Emergency department readmission reduction programs Remote patient monitoring © 2023 All Rights Reserved - DocGo PAYERS (<5% OF REVENUES) ▪ ▪ At-home urgent care Hospital readmission reduction programs Care gap closure programs EVENTS (<5% OF REVENUES) ■ Medical services at sports arenas ▪ Employee health at convention centers ▪ Medical standby at concerts and film shoots 5#6DOCGO'S PROPRIETARY TECH PLATFORM MODERN ARCHITECTURE AND DESIGN COMPREHENSIVE SOLUTION FOR MOBILE HEALTH CARE 2 min 100% 24/7 EASY ORDERING Digital requesting via Web, Mobile, EMR integrations including Epic, and partner-ready APIs TOTAL TRANSPARENCY Integrated systems provide real-time updates to hospital staff, providers, patients, and family members DIGITAL ACCESS ▪ Mobile Apps for patient to provider messaging and toll-free access to phone-based support © 2023 All Rights Reserved - DocGo ambuna 5450 Hex 25 MIN The ambuinz 25 W 25, No 4, NY 10016 CONTINUE 09 9 ATLE 21 Box de laget S 14 Our TRIP 1675 TO PEOP Our digital platform is integrated with industry standard EHRS and provides a seamless care logistics experience throughout the patient journey EHR INTEGRATION Integrated with leading EHRs to enhance value and ease adoption of DocGo services Epic athenahealth PROPRIETARY TECHNOLOGY AND UX ■ DocGo's technology platform and self-service Uls facilitate service delivery and results data Proprietary fleet management (CAD) system with Al-enabled routing and Google traffic integration PATIENT-FACING MOBILE APP ■ ■ DocGo On-Demand for iOS and Android provides instant booking of health care visits, care team messaging, and access to results SHARELINKT ShareLinkTM technology provides hospitals, patients and their caregivers real-time vehicle location, accurate ETAS and peace of mind HIPAA COMPLIANT AND ISO 27001 CERTIFIED TECH Designed for managing sensitive healthcare data, with application infrastructure certification ■ ■ 6#7ENGAGED CLINICIANS DELIVERING BETTER CARE THOUSANDS OF HIGHLY TRAINED CLINICIANS Mobile clinicians consisting of LPNs ■ Paramedics ▪ EMTS RNS, PAs, NPs, MDs ▪ Improved patient care ■ Improved loyalty to company Improved insurance rates © 2023 All Rights Reserved - DocGo Ⓡ Improved employee Net Promoter Score Improved facility Net Promoter Score CRUCHUB EXCEPTIONAL EMPLOYEE BENEFITS INCLUDING ▪ Competitive base pay Heavy investment in training ■ Medical insurance ▪ Performance bonus ▪ 401(k) ▪ DocGo Employee Equity Incentive Program DOCGO one medical indeed 4.3 3.2 dispatchhealth 2.7 OAK STREET HEALTH 2.5 Carbon Health 3.0 Ratings as of October 2023 glassdoor 4.1 3.2 3.7 3.6 3.5 7#8SEGMENT OVERVIEW MOBILE HEALTH Mobile Health represents approximately 75% of revenues ▪ DocGo charges a fixed rate per day, per vehicle and per clinician, mitigating volume-based revenue and margin risk ▪ Ability to deliver quality care at lower cost due to on-site LPN / remote APP combination Population health programs that provide medical health, behavioral health, case management and additional services for municipalities ■ Contract terms tend to be one year with auto renew feature for municipal contracts, 2-3 years for state programs and 3+ years for federal contracts ▪ Help prevent unnecessary hospital visits with ED avoidance programs estimated to have saved our customers over $200M to date Significant customers include the City of New York, Jefferson Health, Aetna and Fresenius Medical Care © 2023 All Rights Reserved - DocGo DOCGO Request a Visit ON DEMAND 844-44DOCGO MOBILE URGENT CARE TOTAL ADDRESSABLE MARKET $265 BILLION* *US At Home Care. Sources: McKinsey "Telehealth: A quarter trillion- dollar post COVID-19 reality?" (report published 5/29/20), and, McKinsey "From facility to home: How healthcare could shift by 2025" (report published February 2022) 8#9SEGMENT OVERVIEW MEDICAL TRANSPORTATION Medical Transportation represents approximately 25% of revenues ▪ Provide non-emergency medical transport between clinical settings and/or patient's residences ▪ Insurance/Medicare/Medicaid and facility pay ▪ Transitioning legacy "fee for service" contracts to more lucrative leased hour contracts that provide greater financial predictability, approximately $1,500 per day for dedicated two-person crew and ambulance ▪ Gross Margin target of 30%+ ▪ Significant opportunity to cross-sell mobile health services Major customers include NYC Health + Hospitals, NHS England, Northwell, Jefferson © 2023 All Rights Reserved - DocGo ambaln TOTAL ADDRESSABLE MARKET $7-$13 BILLION* *Source: US, Ambulance Only. Management estimates. 9#10ILLUSTRATIVE CUSTOMERS, PARTNERS AND PROJECTS LEADING HEALTH SYSTEMS, PAYERS, CORPORATIONS AND MUNICIPALITIES GOVERNMENT/PUBLIC HEALTH CARE SYSTEMS RTMENT DEPARTA OF IN UNITED STATES OF NHS England ERICA S HEALTH MDHHS U.S. Department of Defense Michigan Department of Health & Human Services USA & HUMAN NYC Health NEW YORK Department STATE OF OPPORTUNITY. of Health SERVICES © 2023 All Rights Reserved - DocGo ARIZONA 家 MK COUNTY ANTON HEALTH dhec Healthy People. Healthy Communities. bo • PHS 1955 FRESENIUS MEDICAL CARE J TM Catholic Health HCA St. Catherine of Siena Hospital Jefferson Philadelphia University + Thomas Jefferson University HOME OF SIDNEY KIMMEL MEDICAL COLLEGE Mount Sinai uchealth Northwell HealthⓇ TriStar Healthcare™ Division 非 UTHealth NYC HEALTH+ HOSPITALS ♡♡♡ Martin Luther King, Jr. Community Hospital PAYORS Empire. HealthPlus Horizon. Cigna. Braven™ HEALTH EmblemHealth United Healthcare Ⓡ L.A. Care HEALTH PLAN Elevance Health Clover aetna Health 10#11OUR FOOTPRINT AND REACH DocGo provides services in 30 US states and the UK Can facilitate clinical services in 38 states <1% market penetration today © 2023 All Rights Reserved - DocGo Medical Transport Only (2) Mobile Health Only (28) Mobile Health & Medical Transport (7) 11#12VERTICAL INTEGRATION CREATES OUR COMPETITIVE MOAT PROPRIETARY TECHNOLOGY AND EMR INTEGRATIONS RAPIDLY DEPLOYABLE STAFF ➜ 18 LABORATORY LICENSE CLINICAL PRACTICE GROUP MEDICATION DISPENSORY MEDICARE AND MANAGED CARE CREDENTIALS 8 © 2023 All Rights Reserved - DocGo li+ ooooo ooooo Technology is the nucleus of the value proposition via a proprietary platform that utilizes Al optimization, patient EHR, Hospital integration, and technology-based staffing Winning deals against competitors is attributed to rapidly deployed programs based on 'just-in-time' staffing solutions Licensure enables the company to facilitate the collection, processing, diagnostics and follow up Physicians practice positions our service offering as a nimble alternative to traditional primary and urgent care Ability to act as a wholesale pharmacy creates a more streamlined, integrated patient care experience Diverse managed care credentials developed competency for health record management and billing for services DocGo has continued to expand its moat, preserving its value proposition by relying on technology to efficiently deploy our resources. The formulaic balance of Al and human specialty has improved DocGo's unit economics, positioning the company to disrupt both its competitors and the healthcare market overall. 12#13PILOT PROGRAMS DocGo is providing on-demand care to patients where and when they need it, all done outside the traditional four walls of the medical establishment DocGo is partnering with household brands to leverage our technology and reach, including innovative partnerships that utilize co-branded offerings to facilitate patient care DOLLAR GENERAL Cigna Empire BLUE CROSS aetna™ DOLLAR GENERAL Limited pilot program providing basic primary and urgent care to select Dollar General locations in Tennessee Dollar General has 19,000 locations in the US, 70% of which are attractive prospects Initial pilot includes a mobile unit rotati Urgent care type reimbursement model cross 3 stores INSURANCE COMPANIES Contracted to help close care gaps and provide urgent care and preventative health care services to five insurance companies including Aetna, Cigna and Horizon BCBS Insurers covering approximately 10M lives Ability to scale nationally if programs demonstrate success © 2023 All Rights Reserved - DocGo DOCGO ON DEMAND Gary and Mary west tpace DOCGO ON-DEMAND Providing primary and urgent care type services at select locations in the Northeast Over 4,700 patient interactions to date - accumulating data to study unit economics Transformative proposition to consumers in need of routine care REMOTE PATIENT MONITORING Partnered with West Pace in San Diego to remotely monitor at-risk senior populations When outside parameters, DocGo can provide home visits to remedy and avoid costly ER admissions Collect data to support the unit economic model for both DocGo and payers 13#14Q3 2023 FINANCIAL UPDATE Q3 2023 FINANCIAL HIGHLIGHTS Q3 2023 BUSINESS HIGHLIGHTS ▪ Total Q3 2023 revenue was $186.6 million, as compared to $104.3 for the comparable period in 2022, an increase of 79% ▪ Adjusted EBITDA(a) for Q3 2023 was $16.7 million ■ Net Income for Q3 2023 was $4.6 million ▪ Mobile Health revenue for Q3 2023 was $139.3 million as compared to $76.6 million for Q3 2022, an increase of ~82% ▪ Transportation Services revenue was $47.2 million compared to $27.7 million for Q3 2022, an increase of ~70% © 2023 All Rights Reserved - DocGo Continued to expand services with current partners, signing new customers and winning RFPs UK-based subsidiary Ambulnz Community Partners Ltd. awarded a 5-year contract for emergency and urgent ambulance services Announced partnership with Main Line Health in Philadelphia for medical transportation and collaboration on remote patient monitoring ▪ Launched partnership with EmblemHealth for Mobile Health ▪ Continued expansion of serviced locations NYC contract to provide healthcare and basic services to migrant populations ~158,000 patients transported, ~50,000 patients engaged, ~46,000 received remote monitoring services ▪ Expanded ability to facilitate clinical services and close over 30 different care gaps in patients' homes on behalf of major insurance companies ($ in millions) 108.8 71.8 $37.0 Q4 2022 Quarterly Revenue $72.9 $40.1 $113.0 Q1 2023 Transportation $125.5 $80.1 $45.4 Q2 2023 Mobile Health $139.3 $47.2 $186.6 Q3 2023 ■ Total (a) Adjusted EBITDA is a non-GAAP measure. See Appendix for a reconciliation to the most comparable GAAP measure. 14#15GROWTH DRIVERS DocGo's growth strategy will be fueled by the following key components LEGACY CUSTOMERS MOBILE HEALTH PILOTS PAYER PILOT VIRTUAL CARE MANAGEMENT RFP CHANNEL M&A CHANNEL © 2023 All Rights Reserved - DocGo Continue expansion of existing customers with 3, 4, 5th generation contracts Reduce Emergency Department admissions and hospital readmissions Care gap closure programs provide patient volume with no customer acquisition costs ➜ Proactive remote monitoring and health coaching for patients with chronic diseases Large federal and state-level opportunities represent multi-million-dollar deals Disciplined M&A approach will continue to gain access to new services and regions 15#16EXPERIENCED LEADERSHIP TEAM STAN VASHOVSKY Co-Founder, Non-Executive Chairman of the Board Founded DocGo (f/k/a Ambulnz) in 2015 with the vision to revolutionize medical transportation and healthcare delivery ■ Previously executive for services innovations at Philips Healthcare ■ 25+ years of healthcare experience including paramedic work LEE BIENSTOCK Chief Executive Officer Joined DocGo in March 2022 as Chief Operating Officer Promoted to President in January 2023, and CEO in Sep ember 2023 Spent 10 years at Google, where he most recently served as Global Head of Enterprise Partnerships for Devices and Services ▪ MBA from the Wharton School of Business NORM ROSENBERG Chief Financial Officer and Treasurer Joined DocGo in January 2020 as CFO of Ambulnz Holdings, LLC ■ Promoted to CFO of DocGo Inc. in January 2023, and Treasurer in September 2023 More than 20 years experience as CFO in various companies including telecom and insurance industries Andre Oberholzer EVP of Strategy Ely Tendler General Counsel Stephen Sugrue Chief Compliance Officer Hawk Newton Chief Technology Officer Rosemarie Milano SVP, Human Resources Dr. James Powell CEO, Clinical Practice Group Ahron Weiner Chief Marketing Officer 16#17KEY TAKEAWAYS Rapid revenue growth, nine quarters of positive adjusted EBITDA, history of Beating revenue expectations and raising guidance Traction with multiple multi-billion dollar healthcare market segments Defensible competitive technology advantage and vertical integration Unique value proposition to healthcare systems and patients Early stages of accelerating recurring revenue growth Highly attractive customer base Mission-driven company with world-class management team © 2023 All Rights Reserved - DocGo *am AMBULANCE THOD ON DEMAND 17#18WHERE HOMEBOUND PATIENTS BENEFIT FROM ONSITE TREATMENT, WE GO. WHERE LONG WAITS IN BUSY EMERGENCY ROOMS DO MORE HARM THAN GOOD, WE GO. WHERE UNDERSERVED POPULATIONS NEED BETTER CARE, WE GO. WHERE BASIC TELEHEALTH PROVIDERS STOP, WE GO. AND WHEN ALL REASON SAYS IT CAN'T BE DONE, LEAVE WELL ENOUGH ALONE AND QUIT WHILE YOU'RE AHEAD, WE DO WHAT OUR COMPANY HAS ALWAYS DONE. WE GO. DOCGO © 2023 All Rights Reserved - DocGo#19APPENDIX: RECONCILIATION OF NON-GAAP MEASURES The table below reflects the reconciliation of net income to Adjusted EBITDA for the nine months ended September 30, 2023. (in $ millions) Net Income/(loss) (GAAP) (+) Net Interest expense/(income) (+) Income Tax (+) Depreciation & amortization (+) Other (income)/expense EBITDA (+) Non-cash stock compensation (+) Non-recurring expense Adjusted EBITDA © 2023 All Rights Reserved - DocGo Q3 2023 $4.6 ($0.3) $4.5 $4.3 ($0.1) $13.0 $3.4 $0.3 $16.7 19